Stock 301033 MEDPRIN REGENERATIVE MEDICAL TECHNOLOGIES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Medprin Regenerative Medical Technologies Co., Ltd.

Equities

301033

CNE100004NB8

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 08/05/2024 am IST 		5-day change 1st Jan Change
42.5 CNY +12.43% Intraday chart for Medprin Regenerative Medical Technologies Co., Ltd. +23.19% -2.39%
24/04 Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
18/04 Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tranche Update on Medprin Regenerative Medical Technologies Co., Ltd.'s Equity Buyback Plan announced on February 23, 2024.
CI
Medprin Regenerative Medical Technologies Co., Ltd. announces an Equity Buyback for CNY 20 million worth of its shares.
CI
Medprin Regenerative Medical Technologies Co., Ltd. authorizes a Buyback Plan.
CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Certain A Shares of Medprin Regenerative Medical Technologies Co., Ltd. are subject to a Lock-Up Agreement Ending on 26-JUL-2023.
CI
Medprin Regenerative Medical Technologies Co., Ltd. Approves Final Cash Dividend for the Year 2022, Payable on 01 June 2023
CI
Medprin Regenerative Medical Technologies Co., Ltd. Proposes Profit Distribution of Cash Dividend for the Year 2022
CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Medprin Regenerative Medical Gets Marketing Nod in China for Craniofacial Fixation Plate
MT
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Certain A Shares of Medprin Regenerative Medical Technologies Co., Ltd. are subject to a Lock-Up Agreement Ending on 26-JUL-2022.
CI
Medprin Regenerative Medical Technologies to Free Up 2.5% Stake For Trading
MT
Medprin Regenerative Medical Technologies Co., Ltd. Approves Profit Distribution Plan for 2021
CI
Medprin Regenerative Medical Technologies Co., Ltd. Announces Profit Distribution for 2021
CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 301033 Stock
  4. News Medprin Regenerative Medical Technologies Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW